These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3194893)

  • 21. THE SEPARATION OF AUTOPROTHROMBIN I-C FROM BOVINE PROTHROMBIN PREPARATIONS.
    SEEGERS WH; KAGAMI M
    Can J Biochem; 1964 Sep; 42():1249-62. PubMed ID: 14217232
    [No Abstract]   [Full Text] [Related]  

  • 22. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation.
    Sakai T; Lund-Hansen T; Paborsky L; Pedersen AH; Kisiel W
    J Biol Chem; 1989 Jun; 264(17):9980-8. PubMed ID: 2785997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature.
    Thorsen S; Teisner A; Jensen SA; Philips M; Dalhoff K; Bendtsen F
    Scand J Clin Lab Invest; 2009; 69(6):643-50. PubMed ID: 19530032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical use of a test for determination of coagulation factors II, X and VII].
    Cascino A; Cangiano C; Attili AF
    Minerva Med; 1975 Aug; 66(55):2743-9. PubMed ID: 1161171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of factor X and prothrombin in antithrombin-III depleted plasma: the effects of heparin.
    Ofosu FA; Blajchman MA; Modi G; Cerskus AL; Hirsh J
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):331-45. PubMed ID: 7324001
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular changes during prothrombin activation.
    Engel AM; Alexander B
    Biochim Biophys Acta; 1973 Oct; 320(3):687-700. PubMed ID: 4796208
    [No Abstract]   [Full Text] [Related]  

  • 28. ACTIVATION OF FACTOR X.
    LECHNER K; DEUTSCH E
    Thromb Diath Haemorrh; 1965 Jun; 13():314-29. PubMed ID: 14347857
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanism of thrombinogenesis inhibition by phosphatidyl serine].
    Tersenov OA; Byshevskiĭ ASh
    Ukr Biokhim Zh (1978); 1981; 53(6):26-30. PubMed ID: 7324188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade.
    Altieri DC; Morrissey JH; Edgington TS
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7462-6. PubMed ID: 2971972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study.
    McGee MP; Wallin R; Wheeler FB; Rothberger H
    Blood; 1989 Oct; 74(5):1583-90. PubMed ID: 2790188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation factors in chronic liver disease.
    Donaldson GW; Davies SH; Darg A; Richmond J
    J Clin Pathol; 1969 Mar; 22(2):199-204. PubMed ID: 5776551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiserum against factor IX shortens the bovine thromboplastin coagulation time of human plasma.
    Orstavik KH; Laake K
    Thromb Res; 1978 Mar; 12(3):455-65. PubMed ID: 653636
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of factor V, VII and X activities, the key coagulant proteins of the tissue factor pathway in poultry plasma.
    Thomson AE; Squires EJ; Gentry PA
    Br Poult Sci; 2002 May; 43(2):313-21. PubMed ID: 12047098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preparation of activated factor X and its action on prothrombin.
    Jesty J; Esnouf MP
    Biochem J; 1973 Apr; 131(4):791-9. PubMed ID: 4737325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TISSUE EXTRACTS AND THEIR SENSITIVITY TO FACTOR VII AND FACTOR X.
    DENSON KW
    Thromb Diath Haemorrh; 1964 Apr; 11():146-54. PubMed ID: 14171582
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
    Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
    Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
    Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.